Four-Year Visual Outcomes After Intravitreous Aflibercept for Vision-Threatening Complications of Diabetic Retinopathy.

Kanclerz, Piotr; Tuuminen, Raimo

Kanclerz, Piotr; Tuuminen, Raimo.

Affiliation

Kanclerz P; Hygeia Clinic, Gdansk, Poland.
Tuuminen R; Helsinki Retina Research Group, University of Helsinki, Helsinki, Finland.

JAMA ; 329(20): 1795-1796, 2023 05 23.

Article in En | MEDLINE | ID: mdl-37219557

Subject(s)

Angiogenesis Inhibitors; Blindness; Diabetes Mellitus; Diabetic Retinopathy; Humans; Diabetic Retinopathy/complications; Diabetic Retinopathy/drug therapy; Angiogenesis Inhibitors/administration & dosage; Angiogenesis Inhibitors/therapeutic use; Intravitreal Injections; Blindness/etiology; Blindness/prevention & control

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Blindness / Angiogenesis Inhibitors / Diabetes Mellitus / Diabetic Retinopathy Type of study: Etiology_studies Limits: Humans Language: En Journal: JAMA Year: 2023 Document type: Article Affiliation country: Poland Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google